Two Sigma Investments’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-297,129
Closed -$208K 3405
2023
Q1
$208K Buy
297,129
+5,183
+2% +$4.77K ﹤0.01% 2541
2022
Q4
$263K Buy
291,946
+281,417
+2,673% +$815K ﹤0.01% 2294
2022
Q3
$63K Sell
10,529
-3,140
-23% -$17.8K ﹤0.01% 2293
2022
Q2
$57K Sell
13,669
-37,405
-73% -$132K ﹤0.01% 2333
2022
Q1
$194K Sell
51,074
-47,873
-48% -$216K ﹤0.01% 2342
2021
Q4
$445K Sell
98,947
-35,064
-26% -$178K ﹤0.01% 3362
2021
Q3
$624K Sell
134,011
-166,688
-55% -$883K ﹤0.01% 3053
2021
Q2
$2.12M Buy
300,699
+94,459
+46% +$509K ﹤0.01% 1820
2021
Q1
$1.22M Buy
206,240
+135,130
+190% +$819K ﹤0.01% 2127
2020
Q4
$328K Sell
71,110
-186,260
-72% -$803K ﹤0.01% 2792
2020
Q3
$1M Buy
+257,370
New +$5.17M ﹤0.01% 1755

Two Sigma Investments's STSA Position: Q2 2023 in Review

Two Sigma Investments sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 297,129 shares — an estimated $208K sold.

Two Sigma Investments first reported a position in STSA in Q3 2020 and held it in 11 quarters. The position peaked at $2.12M in Q2 2021. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

  • Two Sigma Investments reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 297,129 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $208K.
  • Two Sigma Investments first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Two Sigma Investments's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $2.12M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.